FDA THREATENS ACCESS TO COMPOUNDED NATURAL MEDICATIONS
A recent ANH-US article highlights many of the differences between synthetic drugs and natural compounded medications for hypothyroidism. It was prompted by the threat of the FDA to restrict or eliminate natural compounded formulas. For many, these compounded natural formulas, are far more effective as they work on the synergy of a number of related hormones. This FDA threat on compounded natural medications shows their bias for big pharma and is not in the best interest of public health. “Hypothyroid patients are just one of the many, many types of patients who will lose access to medicines they rely upon—if the FDA is successful in eliminating compounding.”
